Conflict of Interest Disclosure in Orphan Drug Research

, , , , , &
Ethics in Biology, Engineering and Medicine 5 (3):259-269 (2014)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1615/ethicsbiologyengmed.2015013276

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,219

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

The impact of conflict of interest on trust in science.Paul J. Friedman - 2002 - Science and Engineering Ethics 8 (3):413-420.
Ethical issues in funding orphan drug research and development.C. A. Gericke - 2005 - Journal of Medical Ethics 31 (3):164-168.
Conflict of interest and its significance in science and medicine warsaw, Poland, 5–6 April, 2002.Wendy Baldwin - 2002 - Science and Engineering Ethics 8 (3):469-475.
Failure to discount for conflict of interest when evaluating medical literature: a randomised trial of physicians.G. K. Silverman, G. F. Loewenstein, B. L. Anderson, P. A. Ubel, S. Zinberg & J. Schulkin - 2010 - Journal of Medical Ethics 36 (5):265-270.
Disclosing Conflicts of Interest in Clinical Research: Views of Institutional Review Boards, Conflict of Interest Committees, and Investigators.Kevin P. Weinfurt, Joëlle Y. Friedman, Michaela A. Dinan, Jennifer S. Allsbrook, Mark A. Hall, Jatinder K. Dhillon & Jeremy Sugarman - 2006 - Journal of Law, Medicine and Ethics 34 (3):581-591.
Underreporting of conflicts of interest in clinical practice guidelines: cross sectional study. [REVIEW]Julie Bolette Bindslev, Jeppe Schroll, Peter Gøtzsche & Andreas Lundh - 2013 - BMC Medical Ethics 14 (1):19.
Conflict of interest as seen from a researcher’s perspective.Arrigo Schieppati, Norberto Perico & Giuseppe Remuzzi - 2002 - Science and Engineering Ethics 8 (3):337-342.
A fair share for the orphans: ethical guidelines for a fair distribution of resources within the bounds of the 10-year-old European Orphan Drug Regulation: Figure 1.Wim Pinxten, Yvonne Denier, Marc Dooms, Jean-Jacques Cassiman & Kris Dierickx - 2012 - Journal of Medical Ethics 38 (3):148-153.
Developing model language for disclosing financial interests to potential clinical research participants.K. P. Weinfurt, J. S. Allsbrook, J. Y. Friedman, M. A. Dinan, M. A. Hall, K. A. Schulman & J. Sugarman - 2006 - IRB: Ethics & Human Research 29 (1):1-5.
Conflict of Interest in Industry-Sponsored Clinical Research.Sarah Roberts-Cady - 2010 - International Journal of Applied Philosophy 24 (1):47-59.
Potential research participants' views regarding researcher and institutional financial conflicts of interest.S. Y. H. Kim - 2004 - Journal of Medical Ethics 30 (1):73-79.
Individual and institutional conflict of interest: Policy review by research universities in the united states.Nils Hasselmo - 2002 - Science and Engineering Ethics 8 (3):421-427.
Research, ethics and conflicts of interest.M. Little - 1999 - Journal of Medical Ethics 25 (3):259-262.
Conflict of interest in online point-of-care clinical support websites: Table 1.Kyle T. Amber, Gaurav Dhiman & Kenneth W. Goodman - 2014 - Journal of Medical Ethics 40 (8):578-580.
Researcher Perspectives on Conflicts of Interest: A Qualitative Analysis of Views from Academia.Jensen T. Mecca, Carter Gibson, Vincent Giorgini, Kelsey E. Medeiros, Michael D. Mumford & Shane Connelly - 2015 - Science and Engineering Ethics 21 (4):843-855.

Analytics

Added to PP
2015-04-03

Downloads
21 (#695,936)

6 months
8 (#292,366)

Historical graph of downloads
How can I increase my downloads?

Author Profiles

Daniel Patrone
State University of New York, Oneonta
Wang Ting

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references